Search
betamethasone/calcipotriene (Enstilar)
Indications:
- plaque psoriasis
Dosage:
- apply QD to affected areas for up to 4 weeks. Patients should
- stop when control is achieved
- maximum dose 60 g every 4 days (15 g/day)
alcohol-free foam in a pressurized spray for application to large areas of plaque psoriasis
Adverse effects:
- skin irritation & pruritus at sites of application
- folliculitis,
- skin hypopigmentation
- hypercalcemia
- urticaria
- exacerbation of psoriasis
General
pharmacologic combination
topical agent
dermatologic agent
References
- Brooks M
FDA OKs Topical Drug Combo (Enstilar) for Plaque Psoriasis.
http://www.medscape.com/viewarticle/852952
Components
betamethasone dipropionate; betamethasone valerate (Celestone, Soluspan, Betasone)
calcipotriene; calcipotriol (Dovonex, Dovobet)